A systematic review and meta-analysis of seroprevalence surveys of ebolavirus infection

Scientific Data

Volumn 4, Issue , 2017, Pages

  Bower, Hilary ^a   Glynn, Judith R ^a  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EBOLA HEMORRHAGIC FEVER; EBOLAVIRUS; EPIDEMIC; HUMAN; META ANALYSIS; SEROEPIDEMIOLOGY;

DISEASE OUTBREAKS; EBOLAVIRUS; HEMORRHAGIC FEVER, EBOLA; HUMANS; SEROEPIDEMIOLOGIC STUDIES;

EID: 85011309213     PISSN: None     EISSN: 20524463     Source Type: Journal    
DOI: 10.1038/sdata.2016.133     Document Type: Review

References (75)

1. Tignor, G. H., Casals, J. & Shope, R. E. The yellow fever epidemic in Ethiopia, 1961-1962: retrospective serological evidence for concomitant Ebola or Ebola-like virus infection. Transactions of the Royal Society of Tropical Medicine and Hygiene 87, 162 (1993).
2. van der Groen, G. & Pattyn, S. R. Measurement of Antibodies to Ebola Virus in Human-Sera from Nw-Zaire. Annales de la Societe belge de medecine tropicale 59, 87-92 (1979).
3. Neppert, J., Gohring, S., Schneider, W. & Wernet, P. No Evidence of Lav Infection in the Republic-of-Liberia, West-Africa, in the Year 1973. Blut 53, 115-117 (1986).
4. van der Groen, G., Johnson, K., Webb, F., Wulff, H, Lange, J. in Ebola Virus Haemorrhagic Fever, edPattyn S. R.) 141-142Elsevier/North-Holland Biomedical Press, (1978).
5. The International Commission. Ebola Haemorrhagic Fever in Zaire. Bulletin WHO (1976).
6. WHO International Study Team. Ebola haemorrhagic fever in Sudan, 1976. Report of a WHO/International Study Team. Bulletin of the World Health Organization 56, 247-270 (1978).
7. Heymann, D. L. et al. Ebola Hemorrhagic Fever: Tandala, Zaire, 1977-1978. Journal of Infectious Diseases 142, 372-376 (1980).
8. Knobloch, J., Albiez, E. J. & Schmitz, H. A serological survey on viral haemorrhagic fevers in Liberia. Annales de l'Institut Pasteur/Virologie 133, 125-128 (1982).
9. Baron, R. C., McCormick, J. B. & Zubeir, O. A. Ebola virus disease in southern Sudan: hospital dissemination and intrafamilial spread. Bull World Health Organ 61, 997-1003 (1983).
10. Saluzzo, J. F., Gonzalez, J. P., Herve, J. P., Georges, A. J. & Johnson, K. M. Preliminary note on the presence of antibodies to Ebola virus in the human population in the eastern part of the Central African Republic. Bulletin de la Societe de pathologie exotique et de ses filiales 73, 238-241 (1980).
11. Bouree, P. & Bergmann, J.-F. Ebola Virus Infection in Man: A Serological and Epidemiological Survey in the Cameroons. The American Journal of Tropical Medicine and Hygiene 32, 1465-1466 (1983).
12. Smith, D. H. et al. Marburg-Virus Disease in Kenya. The Lancet 319, 816-820 (1982).
13. Johnson, B. K. et al. Antibodies against haemorrhagic fever viruses in Kenya populations. Transactions of the Royal Society of Tropical Medicine and Hygiene 77, 731-733 (1983).
14. Ivanoff, B. et al. Haemorrhagic fever in Gabon. I. Incidence of Lassa, Ebola and Marburg viruses in Haut-Ogooue. Transactions of the Royal Society of Tropical Medicine and Hygiene 76, 719-720 (1982).
15. Blackburn, N. K., Searle, L. & Taylor, P. Viral haemorrhagic fever antibodies in Zimbabwe schoolchildren. Transactions of the Royal Society of Tropical Medicine and Hygiene 76, 803-805 (1982).
16. Talani, P. K., JD., Gromyko, AI., Nanga-Maniane, J., Yala, F. & Bodzongo, D. Prevelence des anticorps anti-fievres hamorragiques d'origine virale dans la region du Pool (Congo-Brazzaville) Médecine d'Afrique Noire 46 (1999).
17. Van der Waals, F. W., Pomeroy, K. L., Goudsmit, J., Asher, D. M. & Gajdusek, D. C. Hemorrhagic fever virus infections in an isolated rainforest area of central Liberia. Limitations of the indirect immunofluorescence slide test for antibody screening in Africa. Tropical and geographical medicine 38, 209-214 (1986).
18. Jezek, Z., Szczeniowski, M. Y., Muyembe-Tamfum, J. J., McCormick, J. B. & Heymann, D. L. Ebola between Outbreaks: Intensified Ebola Hemorrhagic Fever Surveillance in the Democratic Republic of the Congo, 1981-1985. Journal of Infectious Diseases 179, S60-S64 (1999).
19. Lahm, S. A., Kombila, M., Swanepoel, R. & Barnes, R. F. Morbidity and mortality of wild animals in relation to outbreaks of Ebola haemorrhagic fever in Gabon, 1994-2003. Transactions of the Royal Society of Tropical Medicine and Hygiene 101, 64-78 (2007).
20. Boiro, I. et al. Clinico-epidemiologic and laboratory research on hemorrhagic fevers in Guinea. Bulletin de la Societe de pathologie exotique et de ses filiales 80 607-612 (1987).
21. Gonzalez, J. P. Ebola Virus Circulation in Africa: a balance between clinical expression and epidemiological silence. Epidemiologie 98, 210-217 (2005).
22. Rodhain, F. et al. Arbovirus infections and viral haemorrhagic fevers in Uganda: a serological survey in Karamoja district, 1984. Transactions of the Royal Society of Tropical Medicine and Hygiene 83, 851-854 (1989).
23. Slenczka, W., Rietschel, M., Hoffmann, C. & W, S. Seroepidemiologische Untersuchungen über das Vorkommen von Antikörpern gegen Marburg und Ebola Virus in Afrika. Mitt. Österr. Ges. Tropical Med. Parasitol 6, 53-60 (1984).
24. Meunier, D. M. Y., Dupont, A., Madelon, M. C., Gonzalez, J. P. & Ivanoff, B. Surveillance sérologique des fièvres hémorragiques virales dans le Haut-Ogooue (Gabon). Annales de l'Institut Pasteur/Virologie 138, 229-235 (1987).
25. Meunier, D. M. et al. Current serologic data on viral hemorrhagic fevers in the Central African Republic. Bulletin de la Societe de pathologie exotique et de ses filiales 80, 51-61 (1987).
26. Johnson, E. D., Gonzalez, J. P. & Georges, A. Haemorrhagic fever virus activity in equatorial Africa: distribution and prevalence of filovirus reactive antibody in the Central African Republic. Transactions of the Royal Society of Tropical Medicine and Hygiene 87, 530-535 (1993).
27. Paix, M. A. et al. Serological study of the virus responsible for hemorrhagic fever in an urban population of Cameroon. Bulletin de la Societe de pathologie exotique et de ses filiales 81, 679-682 (1988).
28. Gonzalez, J. P. et al. Antibody prevalence against haemorrhagic fever viruses in randomized representative Central African populations. Research in virology 140, 319-331 (1989).
29. Tessier, S. F., Rollin, P. E. & Sureau, P. Viral haemorrhagic fever survey in Chobe (Botswana). Transactions of the Royal Society of Tropical Medicine and Hygiene 81, 699-700 (1987).
30. Johnson, E. D., Gonzalez, J. P. & Georges, A. Filovirus activity among selected ethnic groups inhabiting the tropical forest of equatorial Africa. Transactions of the Royal Society of Tropical Medicine and Hygiene 87, 536-538 (1993).
31. Tomori, O., Fabiyi, A., Sorungbe, A., Smith, A. & McCormick, J. B. Viral hemorrhagic fever antibodies in Nigerian populations. Am J Trop Med Hyg 38, 407-410 (1988).
32. Mathiot, C. C., Fontenille, D., Georges, A. J. & Coulanges, P. Antibodies to haemorrhagic fever viruses in Madagascar populations. Transactions of the Royal Society of Tropical Medicine and Hygiene 83, 407-409 (1989).
33. US Centers for Disease Control. Update: filovirus infection associated with contact with nonhuman primates or their tissues. MMWR. Morbidity and mortality weekly report 39, 404-405 (1990).
34. Becker, S., Feldmann, H., Will, C. & Slenczka, W. Evidence for Occurrence of Filovirus Antibodies in Humans and Imported Monkeys-Do Subclinical Filovirus Infections Occur Worldwide. Medical microbiology and immunology 181, 43-55 (1992).
35. Busico, K. M. et al. Prevalence of IgG Antibodies to Ebola Virus in Individuals during an Ebola Outbreak, Democratic Republic of the Congo, 1995. Journal of Infectious Diseases 179, S102-S107 (1999).
36. Rowe, A. K. et al. Clinical, virologic, and immunologic follow-up of convalescent Ebola hemorrhagic fever patients and their household contacts, Kikwit, Democratic Republic of the Congo. Journal of Infectious Diseases 179, S28-S35 (1999).
37. Nakounne, E., Selekon, B. & Morvan, J. Microbiological surveillance: viral hemorrhagic fever in Central African Republic: current serological data in man. Bulletin de la Societe de pathologie exotique (1990) 93, 340-347 (2000).
38. Gonzalez, J. P., Nakoune, E., Slenczka, W., Vidal, P. & Morvan, J. M. Ebola and Marburg virus antibody prevalence in selected populations of the Central African Republic. Microbes and Infection 2, 39-44 (2000).
39. Georges, A. J. et al. Ebola hemorrhagic fever outbreaks in Gabon, 1994-1997: epidemiologic and health control issues. The Journal of infectious diseases 179(Suppl 1): S65-S75 (1999).
40. Tomori, O. et al. Serologic Survey among Hospital and Health Center Workers during the Ebola Hemorrhagic Fever Outbreak in Kikwit, Democratic Republic of the Congo, 1995. Journal of Infectious Diseases 179, S98-S101 (1999).
41. Leroy, E. M. et al. Human asymptomatic Ebola infection and strong inflammatory response. The Lancet 355, 2210-2215 (2000).
42. Bertherat, E., Renaut, A., Nabias, R., Dubreuil, G. & Georges-Courbot, M. C. Leptospirosis and Ebola virus infection in five gold-panning villages in northeastern Gabon. The American Journal of Tropical Medicine and Hygiene 60, 610-615 (1999).
43. Heffernan, R. T. et al. Low seroprevalence of IgG antibodies to Ebola virus in an epidemic zone: Ogooue-Ivindo region, Northeastern Gabon, 1997. The Journal of infectious diseases 191, 964-968 (2005).
44. Vladyko, A. S. et al. False-positive reactions in laboratory diagnosis of Lassa, Marburg, and Ebola viral hemorrhagic fevers and AIDS. Russian Progress in Virology 2, 25-30 (1997).
45. Mulangu, S. et al. High prevalence of IgG antibodies to Ebola virus in the Efe pygmy population in the Watsa region, Democratic Republic of the Congo. Bmc Infectious Diseases 16, 263 (2016).
46. Nkoghe, D. et al. Risk factors for Zaire ebolavirus-specific IgG in rural Gabonese populations. The Journal of infectious diseases 204(Suppl 3): S768-S775 (2011).
47. Clark, D. V. et al. Long-term sequelae after Ebola virus disease in Bundibugyo, Uganda: a retrospective cohort study. The Lancet Infectious Diseases 15, 905-912 (2015).
48. Moyen, N. et al. Risk Factors Associated with Ebola and Marburg Viruses Seroprevalence in Blood Donors in the Republic of Congo. PLoS neglected tropical diseases 9, e0003833 (2015).
49. Fallah, M. & PREVAIL III Research Team. A cohort study of survivors of Ebola Virus Infection in Liberia. Conference on Retroviruses and Opportunistic Infections (CROI). At: http://www.croiwebcasts.org/console/player/29569?mediaType=slide Video& (2016).
50. Richardson, E. T. et al. Minimally Symptomatic Infection in an Ebola 'Hotspot': A Cross-Sectional Serosurvey. PLoS neglected tropical diseases 10, e0005087 (2016).
51. Glynn, J. B. et al. Asymptomatic infection and unrecognised Ebola Virus Disease, Sierra Leone (Filovirus 2016 Symposium, Antwerp, Belgium (2016).
52. Kuhn, J. H. & Calisher, C. H. Filoviruses: a compendium of 40 years of epidemiological, clinical and laboratory studies. Springer Science and Business Media, (2008).
53. Becquart, P. et al. High Prevalence of Both Humoral and Cellular Immunity to Zaire ebolavirus among Rural Populations in Gabon. Plos One 5, e9126 (2010).
54. Lambe, T. et al. Detection of Vaccine-Induced Antibodies to Ebola Virus in Oral Fluid. Open forum infectious diseases 3, ofw031 (2016).
55. Remoin, A. et al. Persistent Immune Response in Ebola Survivors from Yambuku Outbreak 40 years after Infection (Filovirus 2016 Symposium, Antwerp, Belgium (2016).
56. Wauquier, N., Becquart, P., Gasquet, C. & Leroy, E. M. Immunoglobulin G in Ebola outbreak survivors, Gabon. Emerg Infect Dis 15, 1136-1137 (2009).
57. Expert committee on Biological Standardisation. WHO collaborative study to assess the suitability of an interim standard for antibodies to Ebola virus. Report No. WHO/BS/2015.2280 post-ECBS, (World Health Organisation (2015).
58. de La Vega, M. A. et al. Ebola viral load at diagnosis associates with patient outcome and outbreak evolution. The Journal of clinical investigation 125, 4421-4428 (2015).
59. Pattyn, S. R. Ebola Virus Haemorrhagic Fever: Proceedings of an International Colloquium on Ebola Virus Infection and Other Haemorrhagic Fevers held in Antwerp, Belgium, 6-8 December, 1977. Elsevier/North-Holland Biomedical Press, (1978).
60. Nyaga, V. N., Arbyn, M. & Aerts, M. Metaprop: a Stata command to perform meta-analysis of binomial data. Archives of Public Health 72, 39 (2014).
61. Higgins J. & Green S.(eds)in The Cochrane Handbook for Systematic Reviews of Interventions (Version 5.1.0) (The Cochrane Collaboration).
62. Wulff, H. & Lange, J. Indirect Immunoflouresce for the diagnosis of Lassa Fever Infection. Bulletin of the World Health Organization 52, 429-436 (1975).
63. Johnson, K. M., Elliott, L. H. & Heymann, D. L. Preparation of polyvalent viral immunofluorescent intracellular antigens and use in human serosurveys. Journal of clinical microbiology 14, 527-529 (1981).
64. Gardner, P. S. & McQuillin, J. Rapid virus diagnosis, application of immunoflourescence. (Butterworth & Co, 1974).
65. Bashkirtsev, V. N., Tkachenko, E. A., Dzagurova, T. K. & Ryl'tseva, E. V. Isolation of strains of the virus of hemorrhagic fever with renal syndrome in cell culture. Voprosy virusologii 29, 497-502 (1984).
66. Emmerich, P. et al. Reverse ELISA for IgG and IgM antibodies to detect Lassa virus infections in Africa. Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 37, 277-281 (2006).
67. Ksiazek, T. G., West, C. P., Rollin, P. E., Jahrling, P. B. & Peters, C. J. ELISA for the Detection of Antibodies to Ebola Viruses. Journal of Infectious Diseases 179, S192-S198 (1999).
68. Schoepp, R. J., Rossi, C. A., Khan, S. H., Goba, A. & Fair, J. N. Undiagnosed acute viral febrile illnesses, Sierra Leone. Emerg Infect Dis 20, 1176-1182 (2014).
69. Boisen, M. L. et al. Multiple circulating infections can mimic the early stages of viral hemorrhagic fevers and possible human exposure to filoviruses in Sierra Leone prior to the 2014 outbreak. Viral immunology 28, 19-31 (2015).
70. Niklasson, B., Peters, C. J., Grandien, M. & Wood, O. Detection of human immunoglobulins G and M antibodies to Rift Valley fever virus by enzyme-linked immunosorbent assay. Journal of clinical microbiology 19, 225-229 (1984).
71. Rezapkin, G. V., Tkachenko, E. A., Ivanov, A. P., Bashkirtsev, V. N. & Dzagurova, T. K. Determination of arenavirus antigens and antibodies by solid-phase radioimmunological analysis. Voprosy virusologii 459-462 (1981).
72. Johnson, B. K. et al. Viral haemorrhagic fever surveillance in Kenya, 1980-1981. Tropical and geographical medicine 35, 43-47 (1983).
73. US Centers for Disease Control. Update: evidence of filovirus infection in an animal caretaker in a research/service facility. MMWR. Morbidity and mortality weekly report 39, 296-297 (1990).
74. US Centers for Disease Control. Update: filovirus infections among persons with occupational exposure to nonhuman primates. MMWR. Morbidity and mortality weekly report 39, 266-267, 273 (1990).
75. Alpha Diagnostic International, I. Zaire-Ebola virus nucleoprotein (EBOV-NP) IgG (AE-320520-1) kit and IgM (AE-320530-1) ELISA kit product descriptions. http://www.4adi.com/ (2016).